Evidence map›Paper›PMID 31824143›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2019

Repetitive Saliva Swallowing Test Predicts COPD Exacerbation.

Yuki Yoshimatsu, Kazunori Tobino, Takuto Sueyasu, Saori Nishizawa, Yuki Ko, Mina Yasuda, Hiromi Ide, Kosuke Tsuruno, Hiroyuki Miyajima

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuki YoshimatsuDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.ORCID 0000-0003-0913-3507
Kazunori TobinoDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Takuto SueyasuDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Saori NishizawaDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Yuki KoDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Mina YasudaDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Hiromi IdeDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Kosuke TsurunoDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Hiroyuki MiyajimaDepartment of Respiratory Medicine, Iizuka Hospital, Fukuoka 820-8505, Japan.
Aso Iizuka Hospital · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Predicting phenotypes at risk of chronic obstructive pulmonary disease (COPD) exacerbation is extremely important. Dysphagia is becoming recognized as one of these phenotypes. A convenient method of screening for dysphagia and COPD exacerbation risk is desired. The repetitive saliva swallowing test (RSST) is one of the least invasive dysphagia screening methods. We previously reported the possible relation between the RSST result and COPD exacerbation in a retrospective study. Based on this, we performed a prospective study to evaluate the efficacy of RSST as a predictor of COPD exacerbation and to determine its optimal cut-off value for COPD. Methods: Seventy patients with COPD were recruited. Patients underwent the following dysphagia screening tests: the 10-item Eating Assessment Tool, Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease, RSST, water swallowing test, and simple swallow provocation test. After one year, they were classified into two groups according to the presence of COPD exacerbation during the follow-up period. Results: Twenty-seven patients had one or more exacerbations in the past year. During the follow-up period, 28 patients had one or more exacerbations (E group), and 42 had none (non-E group). There were no significant differences between the groups except for the presence of past exacerbations and the results of the RSST, when the cut-off value was set at 2, 3, 4, or 5 swallows. The number of swallows in the RSST was significantly lower in the E group than in the Non-E group. A cut-off value of 5 was the most effective. The time to first exacerbation was significantly longer in those with an RSST value of >5. The RSST was more reliable for differentiating the E group and non-E group than the presence of exacerbation in the past year (hazard ratios: 13.78 and 2.70, respectively). Conclusion: An RSST cut-off value of 5 may be a strong predictor of COPD exacerbation.

Indexed as

DeglutitionSalivationAgedAged, 80 and overDeglutition DisordersDisease ProgressionFemaleHumansLungMalePredictive Value of TestsPrognosisProspective StudiesPulmonary Disease, Chronic ObstructiveRisk AssessmentRisk Factorsaspirationdysphagiaphenotyperiskscreening

Identifiers

PMID31824143
PMCPMC6900275
OpenAlexW2993597448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.